We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
CDMO Cambrex likes its deals big or small. In September it closed the $425 million deal acquisition of Halo Pharma. This week it is buying a four-facility competitor in a $250 million deal.
There is more M&A action in the CDMO arena this week as New Jersey-based Cambrex has struck a deal to buy Halo Pharma, picking up two manufacturing facilities in the process.